This webinar was recorded live on May 17, 2023.
It is available on demand through May 31, 2024.
Register above for access.
Description
Genital ulcers, particularly those caused by herpes and syphilis infections, pose both a public health and clinical challenge in the United States, especially in young adults. Molecular methods are commonly limited to diagnosing HSV and VZV with serological methods routinely used for syphilis. Although molecular methods may help with the diagnosis of syphilis, there is no FDA-cleared nucleic acid amplification test (NAAT) for the infection. Therefore, NAAT use is limited. There are also concerns that diagnosis based only on medical history and physical examination may result in inaccuracies and potentially delayed care. Novel approaches, such as syndromic approaches, are important to consider.
In this webinar, Dr. Marty Soehnlen reviews the currently available testing approaches and testing needs for genital ulcers from a clinical vs. public health perspective. Dr. Soehnlen will then discuss the future potential of newer methods when considering a syndromic approach to testing genital ulcers.
Target Audience
This activity is designed for physicians, lab supervisors, lab directors (and/or assistant directors), lab managers (supervisory and/or non-supervisory), pathologists, and other laboratory professionals overseeing/conducting within this topic.
Learning Objectives
After attending this session, participants will be able to:
- Describe current genital ulcer trends and testing methods.
- Explain current approaches, as well as the future potential of new testing methods.
- Discuss and evaluate the value of syndromic approaches to genital ulcer testing.
Faculty
Marty Soehnlen, PhD, MPH, HCLD(ABB)
Director, Division of Infectious Disease
Michigan Department of Health and Human Services, Bureau of Laboratories
Lansing, Michigan, USA
DISCLOSURES AND STATEMENT OF INDEPENDENCE
The Association for Diagnostics & Laboratory Medicine (formerly AACC) is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.
The following faculty reported no relevant financial relationship:
- Marty Soehnlen, PhD, MPH, HCLD(ABB)
CONTENT VALIDITY
All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients; AND/OR all scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.
ACCREDITATION STATEMENT
This activity is approved for 1.0 ACCENT® continuing education credits. Activity ID# 4218. This activity was planned in accordance with ACCENT® Standards and Policies.
SUCCESSFUL COMPLETION STATEMENT
Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email [email protected].